Portfolio (Quarterly)
Guide ↗
Stonepine Capital Management, LLC
· CIK 0001440771| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XBI CALL | SPDR SERIES TRUST | — | 400,000.0 | $51.1M | 20.46% | NEW | — | $127.73 | +4.1% |
| 2 | XBI PUT | SPDR SERIES TRUST | — | 400,000.0 | $51.1M | 20.46% | NEW | — | $127.73 | +4.1% |
| 3 | — | VERASTEM INC | — | 3,302,300.0 | $17.5M | 7.01% | +570K | +20.9% | $5.30 | — |
| 4 | — | TENAX THERAPEUTICS INC | — | 975,200.0 | $15.6M | 6.24% | +963K | +8106.0% | $15.99 | — |
| 5 | ADMA CALL | ADMA BIOLOGICS INC | Healthcare | 1,150,000.0 | $10.4M | 4.15% | NEW | — | $9.01 | -8.7% |
| 6 | EOLS | EVOLUS INC | Healthcare | 1,759,091.0 | $7.2M | 2.90% | +128K | +7.8% | $4.11 | +51.5% |
| 7 | ADMA | ADMA BIOLOGICS INC | Healthcare | 740,000.0 | $6.7M | 2.67% | — | — | $9.01 | -8.7% |
| 8 | CAMP | CAMP4 THERAPEUTICS CORP | Healthcare | 1,389,622.0 | $6.1M | 2.45% | +1.2M | +507.1% | $4.41 | -3.8% |
| 9 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 85,000.0 | $6.1M | 2.45% | — | — | $71.95 | -8.4% |
| 10 | TERN CALL | TERNS PHARMACEUTICALS INC | Healthcare | 100,000.0 | $5.3M | 2.11% | NEW | — | $52.72 | +0.4% |
| 11 | — | ZEVRA THERAPEUTICS INC | — | 480,000.0 | $4.5M | 1.79% | -89K | -15.7% | $9.32 | — |
| 12 | — | CORBUS PHARMACEUTICALS HLDGS | — | 383,462.0 | $3.6M | 1.44% | -6K | -1.7% | $9.39 | — |
| 13 | — | ABEONA THERAPEUTICS INC | — | 746,587.0 | $3.3M | 1.34% | +37K | +5.2% | $4.48 | — |
| 14 | ESTA CALL | ESTABLISHMENT LABS HLDGS INC | Healthcare | 50,000.0 | $2.8M | 1.14% | NEW | — | $56.78 | +29.8% |
| 15 | KZIA | KAZIA THERAPEUTICS LTD | Healthcare | 345,179.0 | $2.6M | 1.03% | -115K | -25.0% | $7.44 | +70.0% |
| 16 | ANTX | AN2 THERAPEUTICS INC | Healthcare | 713,845.0 | $2.4M | 0.98% | +86K | +13.7% | $3.42 | +45.8% |
| 17 | ARE CALL | ALEXANDRIA REAL ESTATE EQ IN | Real Estate | 50,000.0 | $2.3M | 0.93% | — | — | $46.42 | +3.0% |
| 18 | ACAD CALL | ACADIA PHARMACEUTICALS INC | Healthcare | 100,000.0 | $2.2M | 0.89% | NEW | — | $22.26 | -4.9% |
| 19 | SLGL | SOL-GEL TECHNOLOGIES LTD | Healthcare | 27,778.0 | $2.2M | 0.88% | NEW | — | $79.22 | -8.1% |
| 20 | XOMA | XOMA ROYALTY CORPORATION | Healthcare | 69,500.0 | $2.2M | 0.87% | -46K | -39.6% | $31.37 | +32.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%